Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 HKD | +3.09% | -8.26% | -29.58% |
May. 17 | Zhongzhi Pharmaceutical Holdings Limited Approves the Declaration and Payment of Final Dividend | CI |
Mar. 25 | Zhongzhi Pharmaceutical's Attributable Jumps in 2023 | MT |
Sales 2022 | 1.83B 252M 1.97B | Sales 2023 | 2.05B 283M 2.21B | Capitalization | 1.11B 154M 1.2B |
---|---|---|---|---|---|
Net income 2022 | 106M 14.64M 114M | Net income 2023 | 163M 22.51M 176M | EV / Sales 2022 | 0.33 x |
Net cash position 2022 | 225M 31.05M 243M | Net cash position 2023 | 17.45M 2.41M 18.84M | EV / Sales 2023 | 0.54 x |
P/E ratio 2022 |
7.66
x | P/E ratio 2023 |
6.79
x | Employees | 2,643 |
Yield 2022 |
5.51% | Yield 2023 |
6.33% | Free-Float | 24.24% |
1 day | +3.09% | ||
1 week | -8.26% | ||
1 month | -13.04% | ||
3 months | -21.26% | ||
6 months | -30.07% | ||
Current year | -29.58% |
Managers | Title | Age | Since |
---|---|---|---|
Ying Feng Lai
CEO | Chief Executive Officer | 32 | 14-03-31 |
Zhi Tian Lai
FOU | Founder | 57 | 14-09-11 |
Ying Sheng Lai
DFI | Director of Finance/CFO | 31 | 18-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kwun Wan Ng
BRD | Director/Board Member | 61 | 15-06-07 |
Zhi Tian Lai
FOU | Founder | 57 | 14-09-11 |
Li Xia Jiang
BRD | Director/Board Member | 60 | 09-02-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 1 | +3.09% | 41,000 |
24-05-30 | 0.97 | -5.83% | 151,000 |
24-05-29 | 1.03 | -2.83% | 156,000 |
24-05-28 | 1.06 | -0.93% | 101,000 |
24-05-27 | 1.07 | -1.83% | 75,000 |
Delayed Quote Hong Kong S.E., May 31, 2024 at 04:08 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.58% | 110M | |
+15.91% | 41.97B | |
+22.40% | 22.34B | |
+18.48% | 15.25B | |
+16.12% | 14B | |
+45.12% | 12.06B | |
-9.58% | 6.8B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+14.18% | 5.49B |
- Stock Market
- Equities
- 3737 Stock